In the waning days of the Bush administration, the Food and Drug Administration finalized new guidelines that will make it easier to promote the kind of "off-label" drug uses that public health advocates and medical experts say could lead to deadly prescriptions for patients. Robin Briggs, of Cornelius, North Carolina, holds photos of her husband, Douglas, who killed himself after taking Neurontin, a drug approved for epilepsy to help ease his back pain but is suspected of causing suicidal behavior. (Diedra Laird/Charlotte Observer/MCT)
In the waning days of the Bush administration, the Food and Drug Administration finalized new guidelines that will make it easier to promote the kind of "off-label" drug uses that public health advocates and medical experts say could lead to deadly prescriptions for patients. Robin Briggs, of Cornelius, North Carolina, holds photos of her husband, Douglas, who killed himself after taking Neurontin, a drug approved for epilepsy to help ease his back pain but is suspected of causing suicidal behavior. (Diedra Laird/Charlotte Observer/MCT) Diedra Laird / Charlotte Observer / MCT
In the waning days of the Bush administration, the Food and Drug Administration finalized new guidelines that will make it easier to promote the kind of "off-label" drug uses that public health advocates and medical experts say could lead to deadly prescriptions for patients. Robin Briggs, of Cornelius, North Carolina, holds photos of her husband, Douglas, who killed himself after taking Neurontin, a drug approved for epilepsy to help ease his back pain but is suspected of causing suicidal behavior. (Diedra Laird/Charlotte Observer/MCT) Diedra Laird / Charlotte Observer / MCT

Politics & Government

February 01, 2009 12:00 AM

Late move on drugs by Bush FDA could be dangerous

  Comments  

Videos